JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis
This is the second episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "JAK Inhibitors in Action: Effectiveness in Atopic Dermatitis", featuring expert dermatologist Dr. James Song, MD, discusses the following topics: Short- and long-term efficacy and safety data for JAK inhibitor therapies New topline data from the LEVEL UP trial studying upadacitinib in comparison to dupilumab for the treatment of patients aged 12 years and older with moderate-to-severe AD Head-to-head studies and real-world evidence evaluating JAK inhibitor therapies Emerging clinical developments and what's coming next in JAK inhibitor research